Enfermedad de Alzheimer: Actualización en terapia farmacológica / An update on the pharmacological treatment of Alzheimer disease
Rev. méd. Chile
; 133(2): 224-230, feb. 2005. tab
Article
in Spanish
| LILACS
| ID: lil-398057
Responsible library:
CL12.1
RESUMO
Dementia in general, especially Alzheimer disease and vascular dementia, are diseases of high prevalence with severe socio-economic consequences in all countries. In recent years, due to the obtention of new pharmaceutical products acting on different brain neurotransmitters, there has been important changes in the therapy of these diseases. Although these drugs do not stop disease progression, there is consistent evidence of their usefulness in cognitive, behavioral and functional domains and of their pharmaco-economical justification. This article reviews the main drugs available for Alzheimer disease and some future therapeutic perspectives.
Full text:
Available
Collection:
International databases
Database:
LILACS
Main subject:
Vasodilator Agents
/
Neurotransmitter Agents
/
Alzheimer Disease
Type of study:
Risk factors
Limits:
Humans
Language:
Spanish
Journal:
Rev. méd. Chile
Journal subject:
Medicine
Year:
2005
Document type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Hospital del Salvador/CL